| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Veins | 27 | 2021 | 174 | 6.920 |
Why?
|
| Cardiac Surgical Procedures | 73 | 2023 | 1237 | 5.990 |
Why?
|
| Hypoplastic Left Heart Syndrome | 29 | 2023 | 218 | 5.550 |
Why?
|
| Heart Defects, Congenital | 71 | 2023 | 1697 | 4.930 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 11 | 2021 | 31 | 3.860 |
Why?
|
| Fontan Procedure | 20 | 2023 | 155 | 3.710 |
Why?
|
| Norwood Procedures | 17 | 2023 | 84 | 3.540 |
Why?
|
| Pulmonary Artery | 34 | 2023 | 499 | 3.440 |
Why?
|
| Scimitar Syndrome | 11 | 2021 | 53 | 2.720 |
Why?
|
| Heart Ventricles | 28 | 2023 | 846 | 2.660 |
Why?
|
| Tetralogy of Fallot | 14 | 2023 | 149 | 2.600 |
Why?
|
| Heart Arrest, Induced | 13 | 2014 | 87 | 2.530 |
Why?
|
| Ventricular Outflow Obstruction | 16 | 2016 | 88 | 2.480 |
Why?
|
| Sutureless Surgical Procedures | 3 | 2021 | 6 | 2.060 |
Why?
|
| Aorta, Thoracic | 18 | 2021 | 546 | 1.990 |
Why?
|
| Postoperative Complications | 46 | 2021 | 5542 | 1.940 |
Why?
|
| Heart Valve Prosthesis Implantation | 16 | 2020 | 563 | 1.910 |
Why?
|
| Stenosis, Pulmonary Vein | 4 | 2020 | 11 | 1.720 |
Why?
|
| Mitral Valve | 12 | 2020 | 271 | 1.720 |
Why?
|
| Infant, Newborn | 101 | 2022 | 8223 | 1.670 |
Why?
|
| Heart Valve Prosthesis | 10 | 2020 | 386 | 1.650 |
Why?
|
| Mitochondria, Heart | 5 | 2010 | 72 | 1.600 |
Why?
|
| Infant | 116 | 2023 | 13310 | 1.600 |
Why?
|
| Palliative Care | 31 | 2023 | 2037 | 1.570 |
Why?
|
| Coronary Vessel Anomalies | 13 | 2022 | 300 | 1.560 |
Why?
|
| Transposition of Great Vessels | 6 | 2023 | 124 | 1.540 |
Why?
|
| Vascular Surgical Procedures | 16 | 2021 | 655 | 1.490 |
Why?
|
| Bioprosthesis | 5 | 2020 | 167 | 1.410 |
Why?
|
| Reoperation | 42 | 2021 | 1382 | 1.320 |
Why?
|
| Cardiovascular Surgical Procedures | 5 | 2014 | 53 | 1.290 |
Why?
|
| Treatment Outcome | 102 | 2023 | 32848 | 1.090 |
Why?
|
| Thoracic Surgery | 7 | 2022 | 295 | 1.080 |
Why?
|
| Blalock-Taussig Procedure | 8 | 2022 | 48 | 1.070 |
Why?
|
| Heart | 6 | 2023 | 1223 | 1.060 |
Why?
|
| Thorax | 2 | 2023 | 213 | 1.060 |
Why?
|
| Pulmonary Valve | 4 | 2020 | 87 | 1.010 |
Why?
|
| Aortic Coarctation | 5 | 2023 | 103 | 1.000 |
Why?
|
| Heart Septal Defects, Ventricular | 7 | 2012 | 133 | 1.000 |
Why?
|
| Abnormalities, Multiple | 13 | 2016 | 998 | 0.990 |
Why?
|
| Coronary Vessels | 6 | 2022 | 665 | 0.960 |
Why?
|
| Stents | 11 | 2022 | 1096 | 0.950 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2015 | 180 | 0.930 |
Why?
|
| Child, Preschool | 69 | 2022 | 16273 | 0.930 |
Why?
|
| Oxygen Consumption | 12 | 2010 | 401 | 0.920 |
Why?
|
| Hospital Mortality | 17 | 2020 | 1274 | 0.870 |
Why?
|
| Humans | 210 | 2023 | 261506 | 0.870 |
Why?
|
| Embolism, Air | 1 | 2022 | 33 | 0.860 |
Why?
|
| Retrospective Studies | 86 | 2023 | 37905 | 0.830 |
Why?
|
| Aortic Valve Insufficiency | 4 | 2020 | 167 | 0.810 |
Why?
|
| Perfusion | 5 | 2022 | 293 | 0.790 |
Why?
|
| Myocardial Reperfusion Injury | 5 | 2014 | 197 | 0.780 |
Why?
|
| Antlers | 1 | 2020 | 1 | 0.770 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2020 | 21 | 0.760 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 3 | 2010 | 73 | 0.750 |
Why?
|
| Aortic Valve Stenosis | 6 | 2020 | 476 | 0.740 |
Why?
|
| Risk Assessment | 37 | 2021 | 6869 | 0.730 |
Why?
|
| Time Factors | 43 | 2021 | 12926 | 0.730 |
Why?
|
| Child | 64 | 2023 | 29154 | 0.720 |
Why?
|
| Animals, Newborn | 11 | 2014 | 1338 | 0.720 |
Why?
|
| Specialties, Surgical | 1 | 2022 | 137 | 0.700 |
Why?
|
| Risk Factors | 52 | 2023 | 17523 | 0.670 |
Why?
|
| Constriction, Pathologic | 12 | 2018 | 310 | 0.670 |
Why?
|
| Cyclosporine | 3 | 2010 | 278 | 0.670 |
Why?
|
| Male | 123 | 2023 | 123000 | 0.640 |
Why?
|
| Heart Valve Diseases | 5 | 2020 | 193 | 0.630 |
Why?
|
| Vascular Malformations | 5 | 2021 | 83 | 0.610 |
Why?
|
| Survival Analysis | 31 | 2017 | 9180 | 0.610 |
Why?
|
| Pulmonary Circulation | 9 | 2021 | 131 | 0.600 |
Why?
|
| Mitral Valve Stenosis | 3 | 2011 | 50 | 0.580 |
Why?
|
| Female | 124 | 2023 | 141928 | 0.560 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2023 | 67 | 0.550 |
Why?
|
| Cardiopulmonary Bypass | 8 | 2015 | 422 | 0.550 |
Why?
|
| Aortic Valve | 7 | 2020 | 581 | 0.540 |
Why?
|
| Venous Valves | 1 | 2015 | 4 | 0.540 |
Why?
|
| Heart Septal Defects | 5 | 2018 | 51 | 0.540 |
Why?
|
| Pulmonary Valve Insufficiency | 5 | 2023 | 34 | 0.530 |
Why?
|
| Heart Transplantation | 14 | 2021 | 908 | 0.520 |
Why?
|
| Tricuspid Valve | 6 | 2023 | 68 | 0.520 |
Why?
|
| Jugular Veins | 1 | 2015 | 107 | 0.520 |
Why?
|
| Age Factors | 18 | 2020 | 5377 | 0.510 |
Why?
|
| Ventricular Function, Left | 8 | 2018 | 603 | 0.510 |
Why?
|
| Losartan | 1 | 2014 | 46 | 0.490 |
Why?
|
| Societies, Medical | 8 | 2014 | 1335 | 0.490 |
Why?
|
| Echocardiography | 16 | 2018 | 1182 | 0.490 |
Why?
|
| Suture Techniques | 6 | 2018 | 319 | 0.490 |
Why?
|
| Tunica Intima | 1 | 2014 | 117 | 0.480 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2014 | 68 | 0.480 |
Why?
|
| Echocardiography, Transesophageal | 7 | 2018 | 303 | 0.460 |
Why?
|
| Cardioplegic Solutions | 1 | 2013 | 21 | 0.460 |
Why?
|
| Mitochondrial Membranes | 2 | 2010 | 58 | 0.460 |
Why?
|
| Truncus Arteriosus, Persistent | 3 | 2021 | 16 | 0.460 |
Why?
|
| Follow-Up Studies | 32 | 2020 | 14889 | 0.440 |
Why?
|
| Hemodynamics | 12 | 2018 | 935 | 0.440 |
Why?
|
| Adolescent | 45 | 2023 | 31252 | 0.420 |
Why?
|
| Hypertension, Pulmonary | 2 | 2014 | 462 | 0.420 |
Why?
|
| Hospitals | 3 | 2019 | 485 | 0.410 |
Why?
|
| Pulmonary Atresia | 4 | 2016 | 42 | 0.410 |
Why?
|
| Cardiotonic Agents | 2 | 2008 | 151 | 0.400 |
Why?
|
| Coronary Stenosis | 1 | 2012 | 117 | 0.380 |
Why?
|
| Aorta | 5 | 2022 | 692 | 0.380 |
Why?
|
| Survival Rate | 22 | 2020 | 12221 | 0.380 |
Why?
|
| Infant, Low Birth Weight | 3 | 2021 | 181 | 0.380 |
Why?
|
| Databases, Factual | 5 | 2014 | 2218 | 0.380 |
Why?
|
| Heart Bypass, Right | 4 | 2021 | 17 | 0.370 |
Why?
|
| Brachiocephalic Trunk | 2 | 2012 | 43 | 0.370 |
Why?
|
| Myocardial Ischemia | 3 | 2021 | 435 | 0.370 |
Why?
|
| Heterotaxy Syndrome | 2 | 2021 | 63 | 0.360 |
Why?
|
| Replantation | 3 | 2021 | 61 | 0.360 |
Why?
|
| Predictive Value of Tests | 14 | 2020 | 4892 | 0.360 |
Why?
|
| Swine | 8 | 2014 | 1541 | 0.360 |
Why?
|
| Cardiac Catheterization | 10 | 2018 | 687 | 0.350 |
Why?
|
| Postoperative Care | 5 | 2018 | 739 | 0.340 |
Why?
|
| Vena Cava, Superior | 6 | 2012 | 78 | 0.330 |
Why?
|
| Echocardiography, Doppler, Color | 5 | 2018 | 126 | 0.330 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2009 | 76 | 0.330 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2008 | 11 | 0.330 |
Why?
|
| Medical Errors | 3 | 2016 | 219 | 0.320 |
Why?
|
| Thoracotomy | 5 | 2016 | 220 | 0.310 |
Why?
|
| Myocardium | 6 | 2014 | 1313 | 0.300 |
Why?
|
| Length of Stay | 8 | 2021 | 1900 | 0.300 |
Why?
|
| Heart Rate | 2 | 2007 | 737 | 0.300 |
Why?
|
| Patient Selection | 5 | 2021 | 2055 | 0.290 |
Why?
|
| Severity of Illness Index | 10 | 2015 | 4320 | 0.290 |
Why?
|
| Mitochondrial Diseases | 2 | 2008 | 137 | 0.290 |
Why?
|
| Diazoxide | 1 | 2006 | 5 | 0.290 |
Why?
|
| Pericardium | 4 | 2011 | 157 | 0.290 |
Why?
|
| Aortic Stenosis, Supravalvular | 2 | 2020 | 10 | 0.280 |
Why?
|
| Ontario | 11 | 2017 | 98 | 0.280 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2018 | 160 | 0.270 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2022 | 253 | 0.270 |
Why?
|
| Tricuspid Atresia | 2 | 2021 | 12 | 0.270 |
Why?
|
| Lung Transplantation | 2 | 2020 | 359 | 0.260 |
Why?
|
| Coronary Circulation | 5 | 2019 | 253 | 0.260 |
Why?
|
| Biomedical Research | 2 | 2010 | 806 | 0.260 |
Why?
|
| Regional Blood Flow | 4 | 2012 | 276 | 0.260 |
Why?
|
| Sheep | 7 | 2004 | 258 | 0.260 |
Why?
|
| Tracheal Stenosis | 2 | 2020 | 38 | 0.260 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 219 | 0.250 |
Why?
|
| Apoptosis | 7 | 2010 | 7591 | 0.250 |
Why?
|
| Myofibroblasts | 3 | 2015 | 133 | 0.250 |
Why?
|
| Anastomosis, Surgical | 6 | 2014 | 371 | 0.250 |
Why?
|
| Health Status | 3 | 2019 | 590 | 0.250 |
Why?
|
| Cohort Studies | 15 | 2018 | 9244 | 0.250 |
Why?
|
| Cytochromes c | 3 | 2010 | 118 | 0.250 |
Why?
|
| Kaplan-Meier Estimate | 11 | 2014 | 6207 | 0.240 |
Why?
|
| Truncus Arteriosus | 2 | 2021 | 14 | 0.240 |
Why?
|
| Blood Pressure | 4 | 2013 | 1467 | 0.240 |
Why?
|
| North America | 5 | 2019 | 314 | 0.240 |
Why?
|
| Databases as Topic | 2 | 2014 | 133 | 0.240 |
Why?
|
| Blood | 2 | 1995 | 156 | 0.240 |
Why?
|
| Neointima | 2 | 2014 | 53 | 0.240 |
Why?
|
| Canada | 5 | 2018 | 429 | 0.230 |
Why?
|
| Permeability | 3 | 2010 | 167 | 0.230 |
Why?
|
| Ventricular Function, Right | 4 | 2020 | 111 | 0.230 |
Why?
|
| Cardiac Output, Low | 2 | 2014 | 81 | 0.230 |
Why?
|
| Rabbits | 3 | 2010 | 957 | 0.230 |
Why?
|
| Coronary Artery Bypass | 3 | 2014 | 708 | 0.220 |
Why?
|
| Probability | 3 | 2010 | 866 | 0.220 |
Why?
|
| Prognosis | 16 | 2019 | 21713 | 0.220 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2010 | 367 | 0.220 |
Why?
|
| Heart Valves | 3 | 2015 | 66 | 0.220 |
Why?
|
| Echocardiography, Doppler | 6 | 2016 | 180 | 0.220 |
Why?
|
| Analysis of Variance | 5 | 2015 | 2307 | 0.220 |
Why?
|
| Animals | 21 | 2021 | 59536 | 0.220 |
Why?
|
| Cause of Death | 6 | 2020 | 752 | 0.210 |
Why?
|
| Hyperplasia | 2 | 2014 | 557 | 0.210 |
Why?
|
| Disease Models, Animal | 7 | 2014 | 7222 | 0.210 |
Why?
|
| Oxygen | 4 | 2008 | 754 | 0.210 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2014 | 292 | 0.210 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2017 | 435 | 0.210 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 2022 | 137 | 0.210 |
Why?
|
| Myocardial Contraction | 3 | 2008 | 291 | 0.210 |
Why?
|
| Catheterization | 3 | 2012 | 410 | 0.200 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 4314 | 0.190 |
Why?
|
| Prosthesis Failure | 5 | 2020 | 206 | 0.190 |
Why?
|
| Trees | 1 | 2020 | 15 | 0.190 |
Why?
|
| Decision Support Techniques | 2 | 2017 | 622 | 0.190 |
Why?
|
| Ventricular Remodeling | 2 | 2016 | 248 | 0.190 |
Why?
|
| Postoperative Period | 5 | 2011 | 665 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 471 | 0.190 |
Why?
|
| Multivariate Analysis | 8 | 2019 | 4298 | 0.180 |
Why?
|
| Recovery of Function | 4 | 2019 | 703 | 0.180 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 1879 | 0.180 |
Why?
|
| Prospective Studies | 17 | 2021 | 12873 | 0.180 |
Why?
|
| Perioperative Period | 1 | 2020 | 155 | 0.180 |
Why?
|
| Blood Flow Velocity | 7 | 2016 | 475 | 0.180 |
Why?
|
| Vascular Patency | 2 | 2015 | 218 | 0.180 |
Why?
|
| Body Weight | 4 | 2021 | 1293 | 0.170 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2013 | 581 | 0.170 |
Why?
|
| Cyanosis | 3 | 2021 | 40 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 7702 | 0.170 |
Why?
|
| Computed Tomography Angiography | 2 | 2021 | 234 | 0.160 |
Why?
|
| DiGeorge Syndrome | 1 | 2019 | 77 | 0.160 |
Why?
|
| Plant Leaves | 1 | 2018 | 61 | 0.160 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 19 | 0.160 |
Why?
|
| Mitochondria | 2 | 2004 | 1282 | 0.160 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2017 | 11 | 0.160 |
Why?
|
| Ventricular Function | 3 | 2014 | 93 | 0.160 |
Why?
|
| Models, Cardiovascular | 2 | 2012 | 202 | 0.150 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2017 | 44 | 0.150 |
Why?
|
| Chylothorax | 1 | 2017 | 36 | 0.150 |
Why?
|
| Coronary Angiography | 3 | 2016 | 598 | 0.150 |
Why?
|
| Anticoagulants | 3 | 2012 | 787 | 0.150 |
Why?
|
| Birth Weight | 3 | 2023 | 374 | 0.150 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2013 | 412 | 0.150 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1225 | 0.150 |
Why?
|
| Clinical Decision-Making | 2 | 2018 | 524 | 0.150 |
Why?
|
| Data Mining | 1 | 2017 | 88 | 0.150 |
Why?
|
| Health Care Rationing | 1 | 2017 | 94 | 0.150 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2008 | 448 | 0.150 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2016 | 4 | 0.150 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 33 | 0.140 |
Why?
|
| In Vitro Techniques | 2 | 2010 | 1618 | 0.140 |
Why?
|
| Thrombosis | 3 | 2012 | 781 | 0.140 |
Why?
|
| Dobutamine | 1 | 2016 | 54 | 0.140 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2014 | 36 | 0.140 |
Why?
|
| Aortopulmonary Septal Defect | 2 | 2006 | 3 | 0.140 |
Why?
|
| Collateral Circulation | 3 | 2016 | 59 | 0.140 |
Why?
|
| Surgeons | 1 | 2023 | 519 | 0.140 |
Why?
|
| Aortic Diseases | 1 | 2018 | 206 | 0.140 |
Why?
|
| Infant Mortality | 2 | 2014 | 186 | 0.140 |
Why?
|
| Recurrence | 4 | 2021 | 4758 | 0.140 |
Why?
|
| Pleural Effusion | 1 | 2017 | 201 | 0.140 |
Why?
|
| Organ Sparing Treatments | 1 | 2017 | 277 | 0.140 |
Why?
|
| Body Surface Area | 1 | 2015 | 42 | 0.130 |
Why?
|
| Proportional Hazards Models | 7 | 2014 | 4988 | 0.130 |
Why?
|
| Adult | 19 | 2023 | 77950 | 0.130 |
Why?
|
| Phlebography | 1 | 2015 | 76 | 0.130 |
Why?
|
| Heart Block | 3 | 2023 | 48 | 0.130 |
Why?
|
| Medicare | 1 | 2020 | 860 | 0.130 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 74 | 0.130 |
Why?
|
| Mental Health | 1 | 2019 | 415 | 0.130 |
Why?
|
| Regression Analysis | 6 | 2017 | 1546 | 0.130 |
Why?
|
| Multidetector Computed Tomography | 1 | 2016 | 150 | 0.130 |
Why?
|
| Self Report | 1 | 2019 | 756 | 0.130 |
Why?
|
| Chi-Square Distribution | 6 | 2014 | 1323 | 0.130 |
Why?
|
| Parents | 1 | 2021 | 998 | 0.130 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2014 | 14 | 0.130 |
Why?
|
| Survivors | 2 | 2019 | 1031 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 109 | 0.130 |
Why?
|
| Pediatrics | 2 | 2014 | 1141 | 0.120 |
Why?
|
| Ischemic Preconditioning | 1 | 2014 | 20 | 0.120 |
Why?
|
| Stroke Volume | 3 | 2011 | 577 | 0.120 |
Why?
|
| Receptors, Vitronectin | 1 | 2014 | 24 | 0.120 |
Why?
|
| Hospitals, Low-Volume | 1 | 2014 | 53 | 0.120 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2014 | 45 | 0.120 |
Why?
|
| Risk Adjustment | 2 | 2021 | 83 | 0.120 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1994 | 66 | 0.120 |
Why?
|
| Hospitals, High-Volume | 1 | 2014 | 77 | 0.120 |
Why?
|
| Atrioventricular Node | 1 | 2013 | 23 | 0.120 |
Why?
|
| United States | 9 | 2020 | 15433 | 0.120 |
Why?
|
| Young Adult | 9 | 2020 | 21445 | 0.120 |
Why?
|
| Endocardial Cushion Defects | 1 | 2013 | 7 | 0.120 |
Why?
|
| Cardiomegaly | 1 | 2014 | 195 | 0.120 |
Why?
|
| Ventricular Dysfunction | 1 | 2013 | 33 | 0.120 |
Why?
|
| Angioplasty, Balloon | 1 | 2014 | 183 | 0.110 |
Why?
|
| Smad Proteins | 1 | 2013 | 88 | 0.110 |
Why?
|
| Airway Extubation | 1 | 2014 | 65 | 0.110 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 164 | 0.110 |
Why?
|
| Tissue Engineering | 1 | 2015 | 269 | 0.110 |
Why?
|
| Intraoperative Care | 2 | 2011 | 259 | 0.110 |
Why?
|
| Surgical Flaps | 2 | 2017 | 927 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 1999 | 705 | 0.110 |
Why?
|
| Myocardial Reperfusion | 2 | 2008 | 108 | 0.110 |
Why?
|
| Heart Atria | 3 | 2011 | 352 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 333 | 0.110 |
Why?
|
| Systole | 2 | 2009 | 196 | 0.110 |
Why?
|
| Enoxaparin | 1 | 2012 | 66 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 430 | 0.100 |
Why?
|
| Infant, Premature | 2 | 2011 | 787 | 0.100 |
Why?
|
| Incidence | 7 | 2018 | 5673 | 0.100 |
Why?
|
| Registries | 3 | 2014 | 2170 | 0.100 |
Why?
|
| Blood Preservation | 1 | 2011 | 54 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2014 | 299 | 0.100 |
Why?
|
| Pyridones | 1 | 1994 | 348 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2010 | 1493 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 4971 | 0.100 |
Why?
|
| Prosthesis Design | 3 | 2020 | 749 | 0.100 |
Why?
|
| Hypotension | 1 | 2013 | 210 | 0.100 |
Why?
|
| Cadherins | 1 | 2014 | 660 | 0.100 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2010 | 25 | 0.100 |
Why?
|
| Warfarin | 1 | 2012 | 152 | 0.100 |
Why?
|
| Benzopyrans | 1 | 2010 | 41 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2012 | 155 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 348 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2015 | 1244 | 0.090 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2011 | 165 | 0.090 |
Why?
|
| Methylprednisolone | 1 | 2011 | 193 | 0.090 |
Why?
|
| Deoxyglucose | 1 | 2010 | 115 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2012 | 162 | 0.090 |
Why?
|
| Sinus of Valsalva | 1 | 2010 | 53 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 473 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2018 | 2803 | 0.090 |
Why?
|
| Reference Values | 2 | 2012 | 1099 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 192 | 0.090 |
Why?
|
| Gestational Age | 3 | 2020 | 1069 | 0.090 |
Why?
|
| Surgical Instruments | 1 | 2010 | 138 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 2011 | 212 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2015 | 731 | 0.090 |
Why?
|
| Heparin | 1 | 2012 | 360 | 0.090 |
Why?
|
| Ketorolac | 1 | 2009 | 20 | 0.090 |
Why?
|
| Biomarkers | 3 | 2020 | 5047 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2014 | 1385 | 0.090 |
Why?
|
| Heart Arrest | 2 | 2019 | 358 | 0.090 |
Why?
|
| Preoperative Care | 3 | 2018 | 1529 | 0.090 |
Why?
|
| Myocardial Revascularization | 1 | 2009 | 134 | 0.090 |
Why?
|
| Arteriovenous Malformations | 2 | 2010 | 70 | 0.080 |
Why?
|
| Lung | 3 | 2021 | 3151 | 0.080 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2008 | 20 | 0.080 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2010 | 112 | 0.080 |
Why?
|
| Prevalence | 5 | 2018 | 3260 | 0.080 |
Why?
|
| Medical Records | 1 | 2010 | 415 | 0.080 |
Why?
|
| Inflammation | 2 | 2015 | 2522 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2014 | 5637 | 0.080 |
Why?
|
| Algorithms | 3 | 2010 | 3890 | 0.080 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2007 | 17 | 0.080 |
Why?
|
| Heart Function Tests | 1 | 2008 | 73 | 0.080 |
Why?
|
| Radiography, Interventional | 1 | 2010 | 305 | 0.080 |
Why?
|
| Respiratory System Abnormalities | 1 | 2008 | 39 | 0.080 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2007 | 7 | 0.080 |
Why?
|
| Cerebrum | 1 | 2008 | 44 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 973 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2012 | 590 | 0.080 |
Why?
|
| Logistic Models | 3 | 2011 | 3441 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2012 | 621 | 0.080 |
Why?
|
| Endocarditis, Bacterial | 1 | 2008 | 128 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2011 | 629 | 0.070 |
Why?
|
| Respiratory Transport | 1 | 2006 | 2 | 0.070 |
Why?
|
| Radiography | 4 | 2014 | 1904 | 0.070 |
Why?
|
| Endocardium | 1 | 2006 | 50 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 918 | 0.070 |
Why?
|
| Random Allocation | 1 | 2008 | 703 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2007 | 577 | 0.070 |
Why?
|
| Aging | 1 | 1995 | 1582 | 0.070 |
Why?
|
| United States National Aeronautics and Space Administration | 2 | 2016 | 21 | 0.070 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2006 | 54 | 0.070 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2006 | 32 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2008 | 244 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2006 | 145 | 0.070 |
Why?
|
| Nitriles | 1 | 2010 | 906 | 0.070 |
Why?
|
| Oximetry | 4 | 2008 | 172 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 987 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 521 | 0.070 |
Why?
|
| Potassium Channels | 1 | 2006 | 162 | 0.060 |
Why?
|
| Combined Modality Therapy | 4 | 2010 | 8865 | 0.060 |
Why?
|
| Dopamine | 1 | 2006 | 312 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2006 | 217 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 2007 | 230 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 1303 | 0.060 |
Why?
|
| Epidemiologic Methods | 3 | 2009 | 254 | 0.060 |
Why?
|
| Disease Progression | 2 | 2013 | 6682 | 0.060 |
Why?
|
| Linear Models | 3 | 2015 | 1085 | 0.060 |
Why?
|
| Caspases | 2 | 2004 | 661 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2004 | 19 | 0.060 |
Why?
|
| Cytochrome c Group | 1 | 2004 | 71 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2004 | 57 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 571 | 0.060 |
Why?
|
| Spleen | 1 | 2006 | 676 | 0.060 |
Why?
|
| Trachea | 2 | 2020 | 259 | 0.060 |
Why?
|
| Critical Care | 2 | 2009 | 770 | 0.060 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2007 | 318 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1945 | 0.060 |
Why?
|
| Radiology, Interventional | 1 | 2005 | 138 | 0.060 |
Why?
|
| Respiratory Insufficiency | 1 | 2007 | 330 | 0.060 |
Why?
|
| Methods | 1 | 2003 | 189 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 7551 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 980 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2004 | 190 | 0.060 |
Why?
|
| Temperature | 2 | 1995 | 506 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2014 | 6100 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2021 | 925 | 0.050 |
Why?
|
| Phenotype | 1 | 2013 | 6295 | 0.050 |
Why?
|
| Arteries | 1 | 2023 | 274 | 0.050 |
Why?
|
| Fetal Diseases | 1 | 2005 | 388 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 205 | 0.050 |
Why?
|
| Calcium | 1 | 2008 | 1537 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 459 | 0.050 |
Why?
|
| Data Collection | 2 | 2014 | 620 | 0.050 |
Why?
|
| Middle Aged | 8 | 2016 | 86204 | 0.050 |
Why?
|
| Monitoring, Physiologic | 3 | 2012 | 502 | 0.050 |
Why?
|
| Vascular Resistance | 2 | 2015 | 200 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2004 | 3536 | 0.050 |
Why?
|
| Child Development | 2 | 2014 | 255 | 0.050 |
Why?
|
| Drainage | 2 | 2017 | 416 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 360 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2006 | 1245 | 0.050 |
Why?
|
| Terminology as Topic | 2 | 2014 | 414 | 0.050 |
Why?
|
| Comparative Effectiveness Research | 1 | 2021 | 126 | 0.050 |
Why?
|
| Patient Care Management | 1 | 2021 | 94 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1764 | 0.050 |
Why?
|
| Hospitals, Pediatric | 2 | 2018 | 773 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2014 | 125 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2000 | 329 | 0.040 |
Why?
|
| Cattle | 1 | 2021 | 783 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2015 | 2316 | 0.040 |
Why?
|
| Cold Ischemia | 1 | 2019 | 22 | 0.040 |
Why?
|
| Texas | 2 | 2020 | 6311 | 0.040 |
Why?
|
| Drowning | 1 | 2019 | 31 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 46 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 6009 | 0.040 |
Why?
|
| Quality of Life | 3 | 2023 | 4532 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2016 | 1171 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 764 | 0.040 |
Why?
|
| Education, Medical, Continuing | 2 | 2011 | 251 | 0.040 |
Why?
|
| Thoracic Duct | 1 | 2017 | 16 | 0.040 |
Why?
|
| Indoles | 1 | 2004 | 1009 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2000 | 245 | 0.040 |
Why?
|
| Perioperative Care | 2 | 2012 | 451 | 0.040 |
Why?
|
| Retreatment | 1 | 2019 | 452 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 97 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2004 | 1129 | 0.040 |
Why?
|
| Ligation | 1 | 2017 | 193 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 624 | 0.040 |
Why?
|
| Chest Tubes | 1 | 2017 | 101 | 0.040 |
Why?
|
| Operative Time | 1 | 2017 | 217 | 0.040 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2016 | 62 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 2019 | 230 | 0.040 |
Why?
|
| Sternotomy | 1 | 2016 | 58 | 0.040 |
Why?
|
| Heart Failure | 1 | 2010 | 2516 | 0.030 |
Why?
|
| Porosity | 1 | 2015 | 56 | 0.030 |
Why?
|
| Bioreactors | 1 | 2015 | 49 | 0.030 |
Why?
|
| Nanofibers | 1 | 2015 | 22 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2017 | 263 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 609 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2007 | 173 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2019 | 498 | 0.030 |
Why?
|
| Bronchi | 2 | 2008 | 326 | 0.030 |
Why?
|
| Hydrogels | 1 | 2015 | 123 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2019 | 769 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 2488 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 135 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2018 | 1391 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 338 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1994 | 97 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 1994 | 67 | 0.030 |
Why?
|
| Esophagus | 1 | 2017 | 553 | 0.030 |
Why?
|
| Milrinone | 1 | 1994 | 33 | 0.030 |
Why?
|
| Heart Septum | 2 | 2005 | 54 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2015 | 4078 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 1648 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 48 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 136 | 0.030 |
Why?
|
| Microspheres | 1 | 1994 | 210 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 239 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 1995 | 170 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 7548 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2015 | 337 | 0.030 |
Why?
|
| Pregnancy | 4 | 2012 | 7573 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 423 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 233 | 0.030 |
Why?
|
| Program Development | 1 | 2014 | 261 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 554 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 2011 | 38 | 0.030 |
Why?
|
| Blood Safety | 1 | 2011 | 10 | 0.030 |
Why?
|
| Mortality | 2 | 2007 | 343 | 0.030 |
Why?
|
| Exercise Test | 1 | 2013 | 312 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2011 | 2843 | 0.020 |
Why?
|
| Actins | 1 | 2014 | 608 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 1209 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2012 | 231 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2015 | 1038 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 1053 | 0.020 |
Why?
|
| Fibrosis | 1 | 2014 | 793 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2013 | 301 | 0.020 |
Why?
|
| Propensity Score | 1 | 2013 | 750 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 1178 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 216 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 672 | 0.020 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2009 | 19 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 1454 | 0.020 |
Why?
|
| Williams Syndrome | 1 | 2008 | 37 | 0.020 |
Why?
|
| Viridans Streptococci | 1 | 2008 | 17 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 2588 | 0.020 |
Why?
|
| Aortic Arch Syndromes | 1 | 2007 | 11 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2002 | 5270 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2008 | 246 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2013 | 717 | 0.020 |
Why?
|
| Diastole | 1 | 2008 | 187 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2008 | 194 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2007 | 41 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 851 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 2594 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 1972 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 1204 | 0.020 |
Why?
|
| Observer Variation | 1 | 2008 | 671 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2006 | 39 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 233 | 0.020 |
Why?
|
| Biological Transport | 1 | 2008 | 597 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2010 | 10001 | 0.020 |
Why?
|
| Prostaglandins | 1 | 2006 | 77 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2002 | 1498 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 70117 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 280 | 0.020 |
Why?
|
| Germany | 1 | 2005 | 111 | 0.020 |
Why?
|
| Aortography | 1 | 2006 | 181 | 0.020 |
Why?
|
| Airway Obstruction | 1 | 2008 | 261 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2008 | 351 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2005 | 112 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 2007 | 213 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2008 | 474 | 0.020 |
Why?
|
| Critical Pathways | 1 | 2006 | 149 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2007 | 273 | 0.020 |
Why?
|
| Abortion, Induced | 1 | 2005 | 91 | 0.020 |
Why?
|
| Angiography | 1 | 2006 | 360 | 0.020 |
Why?
|
| Device Removal | 1 | 2006 | 337 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2009 | 610 | 0.010 |
Why?
|
| Nuclear Respiratory Factors | 1 | 2002 | 10 | 0.010 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2002 | 18 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 672 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2009 | 732 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2003 | 6150 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2007 | 795 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 698 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2002 | 157 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2009 | 1270 | 0.010 |
Why?
|
| Ovulation | 1 | 2002 | 107 | 0.010 |
Why?
|
| Disease Management | 1 | 2007 | 1052 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 1914 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 869 | 0.010 |
Why?
|
| Ultrafiltration | 1 | 2000 | 22 | 0.010 |
Why?
|
| Decision Making | 1 | 2008 | 1287 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2003 | 501 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2002 | 376 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 315 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 690 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2005 | 830 | 0.010 |
Why?
|
| Weight Gain | 1 | 2003 | 464 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 355 | 0.010 |
Why?
|
| Adenosine | 1 | 2002 | 289 | 0.010 |
Why?
|
| Glycolysis | 1 | 2002 | 519 | 0.010 |
Why?
|
| Comorbidity | 1 | 2006 | 2352 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 3254 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 622 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2002 | 661 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 1999 | 263 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 1130 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2002 | 1555 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 4821 | 0.010 |
Why?
|